Cocrystal Pharma (COCP) Gross Margin (2010 - 2013)
Cocrystal Pharma (COCP) reported Gross Margin of 28.21% for Q2 2013, down 1313.0% on a YoY basis from 2.33% in Q2 2012, and down 3.35% sequentially from 29.18% in Q1 2013.
Cocrystal Pharma (COCP) Gross Margin (2010 - 2013) Analysis & Trends
Cocrystal Pharma (COCP) has 4 years of Gross Margin data on file, last reported at 28.21% in Q2 2013.
- For the quarter ending Q2 2013, Gross Margin fell 1313.0% year-over-year to 28.21%; the trailing twelve-month figure through Jun 2013 stood at 38.34% (up 1013.0% YoY), and the FY2012 full-year result was 42.01%, up 2070.0% from the prior year.
- Gross Margin fell to 28.21% in Q2 2013, from 29.18% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 53.06% in Q3 2011 to a low of 28.42% in Q4 2011.
- A 4-year average of 35.43% and a median of 41.33% in 2012 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin plunged 5871 bps in 2011 and surged 7290 bps in 2012, its largest moves.
- Tracing COCP's Gross Margin over 4 years: stood at 30.29% in 2010, then tumbled by 194 bps to 28.42% in 2011, then soared by 256 bps to 44.48% in 2012, then slumped by 37 bps to 28.21% in 2013.
- Business Quant data shows COCP's Gross Margin at 28.21% in Q2 2013, 29.18% in Q1 2013, and 44.48% in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 88.95% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 28.21% |
| Mar 31, 2013 | 29.18% |
| Dec 31, 2012 | 44.48% |
| Sep 30, 2012 | 41.33% |
| Jun 30, 2012 | 41.34% |
| Mar 31, 2012 | 41.17% |
| Dec 31, 2011 | -28.42% |
| Sep 30, 2011 | 53.06% |
| Jun 30, 2011 | 34.35% |
| Mar 31, 2011 | 46.40% |
| Dec 31, 2010 | 30.29% |
| Sep 30, 2010 | 46.85% |
| Jun 30, 2010 | 52.39% |